Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies

Presenter: Shephal Doshi, Josep Rodés-Cabau, Steven J. Yakubov

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Amulet Tips and Tricks in Simple and Complex Anatomy (With Case Reviews)

Presenter: Shephal Doshi, Josep Rodés-Cabau, DJ Lakkireddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Presenter: William A. Gray, Gregg W. Stone, DJ Lakkireddy

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Intraprocedural Efficiencies

Presenter: Janet F. Wyman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Patient Selection: Making the Subjective Objective (Frailty, Depression)

Presenter: Marian C. Hawkey

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Diagnostic Evaluation: Historical Requirements and Emerging Evidence (LHC, TTE, TEE, CTA, Carotid US, PFTs)

Presenter: Kim Guibone

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Advertisement

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies

Amulet Tips and Tricks in Simple and Complex Anatomy (With Case Reviews)

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Intraprocedural Efficiencies

Patient Selection: Making the Subjective Objective (Frailty, Depression)

Diagnostic Evaluation: Historical Requirements and Emerging Evidence (LHC, TTE, TEE, CTA, Carotid US, PFTs)

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content